Åse Aulie Michelet was born in Oslo 1953 , where she lives today. She holds a degree in pharmacy from the Swiss Federal Institute of Technology Zurich (ETH) and the University of Oslo.
Åse has experience from a range of international boards in several fields. Today she chairs board such as those of BI Norwegian Business School, Spin Chip Diagnostics AS and Inven2 AS and she is a member of the board of Terveystalo Oy in Finland. She was manager and then director of research at Nycomed, president at Amersham AS and CEO of Marine Harvest for two years. She held, among others, the position of CEO at Teres Medical Group AS. Åse has published articles in several publications within pharmacology and toxicology in a range of international journals.